PUBLISHER: The Business Research Company | PRODUCT CODE: 2112408
PUBLISHER: The Business Research Company | PRODUCT CODE: 2112408
Smart pharmaceutical packaging refers to innovative medication packaging solutions embedded with technologies that enable monitoring, protection, and traceability of pharmaceutical products. These systems assist in improving medication safety, verifying product authenticity, overseeing storage conditions, and supporting patient adherence to treatment regimens. The primary objective of smart pharmaceutical packaging is to strengthen pharmaceutical supply chain integrity while promoting improved patient outcomes through real-time monitoring and interactive medication management.
The primary product types of smart pharmaceutical packaging are blister packs, bottles, vials, ampoules, and other product types. Blister packs are unit-dose packaging solutions equipped with smart technologies to improve medication safety, traceability, and patient compliance. These packaging formats incorporate technologies such as radio-frequency identification (RFID), near-field communication (NFC), quick response (QR) codes, temperature-monitoring systems, and other technologies, and are produced using materials including plastic, glass, paper and paperboard, and other materials. Key applications include prescription drug packaging, oral drug packaging, injectable drug packaging, biologics and specialty drug packaging, vaccine packaging, clinical trial packaging, and over-the-counter drug packaging, while end users include healthcare facilities, pharmaceutical companies, contract packaging providers, and others.
Tariffs are influencing the smart pharmaceutical packaging market by increasing the cost of imported electronic components, RFID tags, sensors, and specialized materials used in intelligent drug packaging systems. This is disrupting global supply chains and raising production costs, particularly in regions such as Asia-Pacific and Latin America that depend heavily on imported smart labeling technologies and packaging machinery. Blister packs, smart vials, and RFID/NFC-enabled packaging segments are most affected due to their reliance on high-precision imported inputs. However, tariffs are also encouraging localized manufacturing, regional sourcing of packaging components, and investment in domestic pharmaceutical packaging innovation, which is improving long-term supply chain resilience and technological self-reliance.
The smart pharmaceutical packaging market size has grown rapidly in recent years. It will grow from $3.2 billion in 2025 to $3.57 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to rise in pharmaceutical supply chain counterfeiting concerns, growth in global vaccine distribution programs, increasing regulatory focus on drug safety and traceability, expansion of serialized drug packaging requirements, adoption of barcode-based medication tracking systems.
The smart pharmaceutical packaging market size is expected to see rapid growth in the next few years. It will grow to $5.47 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to growth in personalized medicine and biologics distribution, increasing adoption of connected healthcare ecosystems, rising demand for real-time cold chain monitoring, expansion of digital health and remote patient monitoring, stricter global drug authentication and compliance regulations. Major trends in the forecast period include increasing adoption of iot-enabled smart pharmaceutical packaging for real-time tracking, rising demand for temperature and humidity monitoring packaging in biologics and vaccines, growing integration of anti-counterfeiting and authentication technologies in drug packaging, expansion of patient-centric packaging solutions to improve medication adherence, rising use of rfid, qr codes, and nfc-based smart labeling in pharmaceutical supply chains.
The increasing prevalence of counterfeit pharmaceuticals is expected to drive the growth of the smart pharmaceutical packaging market in the future. Counterfeit pharmaceuticals refer to fake or unauthorized medicines that are deliberately manufactured or distributed with false labeling, incorrect ingredients, improper dosages, or misleading packaging to imitate genuine pharmaceutical products. The rising incidence of counterfeit pharmaceuticals is largely attributed to the expansion of online drug sales platforms, which facilitate unauthorized sellers in distributing fake medicines with limited regulatory monitoring. Smart pharmaceutical packaging assists in reducing counterfeit pharmaceuticals by providing product authentication, real-time tracking, tamper evidence, and supply chain transparency to ensure drug safety and authenticity. For instance, in December 2024, according to the Pharmaceutical Security Institute (PSI), a US-based not-for-profit membership organization, in 2023, the number of reported counterfeit drug incidents reached 6,987 across 142 countries, marking a 4% increase compared to 2022. Therefore, the increasing prevalence of counterfeit pharmaceuticals is driving the growth of the smart pharmaceutical packaging market.
Key companies operating in the smart pharmaceutical packaging market are focusing on developing advanced solutions, such as radio frequency identification (RFID)-enabled smart labels, to improve medication traceability, inventory management, and patient safety across healthcare facilities. RFID-enabled smart labels refer to intelligent packaging components embedded with radio frequency identification technology that enables automatic tracking, identification, and monitoring of pharmaceutical products throughout the supply chain. For example, in October 2023, Fresenius Kabi, a Germany-based healthcare company, launched RFID-enabled labels for Diprivan (propofol injectable emulsion) in the U.S. market. The smart labels are designed to support automated inventory tracking, reduce medication errors, improve workflow efficiency in hospitals, and strengthen pharmaceutical traceability through enhanced digital monitoring capabilities.
In October 2024, Multi-Color Corporation, a US-based prime label solutions company, acquired Starport Technologies for an undisclosed amount. Through this acquisition, Multi-Color Corporation aimed to strengthen its smart packaging and connected label technology capabilities, enhancing product authentication, consumer engagement, and digital traceability solutions for pharmaceutical and consumer goods packaging applications. Starport Technologies, L.L.C. is a US-based smart label company specializing in connected packaging, digital authentication, and traceability solutions for smart pharmaceutical packaging.
Major companies operating in the smart pharmaceutical packaging market are 3M Company; Becton Dickinson and Company; Amcor plc; Avery Dennison Corporation; Sonoco Products Company; Zebra Technologies Corporation; TOPPAN Holdings Inc.; West Pharmaceutical Services Inc.; CCL Industries Inc.; Mondi plc; Nipro Corporation; AptarGroup Inc.; Gerresheimer AG; Stevanato Group; Datwyler Holding Inc.; Winpak Ltd.; Uflex Limited; Jones Healthcare Group; Schott Pharma; Controlant ehf.; Kezzler AS; Origin Pharma Packaging
North America was the largest region in the smart pharmaceutical packaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart pharmaceutical packaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the smart pharmaceutical packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The smart pharmaceutical packaging market includes revenues earned by entities through services such as smart packaging integration, track-and-trace services, anti-counterfeiting solutions, medication adherence monitoring, connected packaging platforms, packaging analytics, regulatory compliance support, and supply chain visibility services. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart pharmaceutical packaging market also includes sales of smart labels, temperature-sensitive packaging systems, tamper-evident packaging, connected packaging devices, printed electronic packaging components, sensors and indicators, and interactive pharmaceutical packaging products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The smart pharmaceutical packaging market research report is one of a series of new reports from The Business Research Company that provides smart pharmaceutical packaging market statistics, including smart pharmaceutical packaging industry global market size, regional shares, competitors with a smart pharmaceutical packaging market share, detailed smart pharmaceutical packaging market segments, market trends and opportunities, and any further data you may need to thrive in the smart pharmaceutical packaging industry. This smart pharmaceutical packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Smart Pharmaceutical Packaging Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses smart pharmaceutical packaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for smart pharmaceutical packaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart pharmaceutical packaging market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.